Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1985 1
1988 1
1989 2
1991 4
1992 1
1993 3
1994 2
1995 1
1996 3
1998 1
2000 2
2001 5
2002 2
2003 1
2004 3
2005 4
2006 1
2007 1
2008 1
2009 1
2010 1
2011 3
2012 1
2013 1
2014 4
2015 6
2016 4
2017 3
2018 4
2019 11
2020 11
2021 2
2022 5
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis.
Mascia G, Crotti L, Groppelli A, Canepa M, Merlo AC, Benenati S, Di Donna P, Della Bona R, Soranna D, Zambon A, Porto I, Olivotto I, Parati G, Brignole M, Cecchi F. Mascia G, et al. Int J Cardiol. 2022 Jun 15;357:88-94. doi: 10.1016/j.ijcard.2022.03.028. Epub 2022 Mar 15. Int J Cardiol. 2022. PMID: 35304190 Review.
AIMS: To describe the proportion of patients with syncope among those affected by hypertrophic cardiomyopathy (HCM) and the relevance of syncope as risk factor for sudden cardiac death and life-threatening arrhythmic events. ...Syncope was reported in 15.8% (3.452 o …
AIMS: To describe the proportion of patients with syncope among those affected by hypertrophic cardiomyopathy (HCM) and the re …
Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.
Weng Z, Yao J, Chan RH, He J, Yang X, Zhou Y, He Y. Weng Z, et al. JACC Cardiovasc Imaging. 2016 Dec;9(12):1392-1402. doi: 10.1016/j.jcmg.2016.02.031. Epub 2016 Jul 20. JACC Cardiovasc Imaging. 2016. PMID: 27450876 Free article. Review.
OBJECTIVES: The aims of this study included performing a meta-analysis of the predictive value of late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) for adverse events and death in hypertrophic cardiomyopathy (HCM). BACKGROUND: CMR with LGE can ident …
OBJECTIVES: The aims of this study included performing a meta-analysis of the predictive value of late gadolinium enhancement (LGE) cardiac …
Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches.
Habib M, Hoss S, Rakowski H. Habib M, et al. Curr Cardiol Rep. 2019 Jun 26;21(8):75. doi: 10.1007/s11886-019-1173-1. Curr Cardiol Rep. 2019. PMID: 31243594 Review.
PURPOSE OF REVIEW: This review discusses the basic and evolving echocardiographic and cardiac magnetic resonance (CMR) approaches in the diagnosis and management of patients with hypertrophic cardiomyopathy (HCM). RECENT FINDINGS: Newer imaging technologies and tech …
PURPOSE OF REVIEW: This review discusses the basic and evolving echocardiographic and cardiac magnetic resonance (CMR) approaches in the dia …
Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW, Cheong JL, Ehrenkranz RA, Halliday HL. Doyle LW, et al. Cochrane Database Syst Rev. 2017 Oct 24;10(10):CD001146. doi: 10.1002/14651858.CD001146.pub5. Cochrane Database Syst Rev. 2017. PMID: 29063585 Free PMC article. Updated. Review.
SEARCH METHODS: For the 2017 update, we used the standard search strategy of Cochrane Neonatal to search the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 1); MEDLINE via PubMed (January 2013 to 21 February 2017); Embase (January 2013 to 21 Fe …
SEARCH METHODS: For the 2017 update, we used the standard search strategy of Cochrane Neonatal to search the Cochrane Central Register of Co …
Thirty-year outcome in children with hypertrophic cardiomyopathy based on the type.
Tsuda E, Ito Y, Kato Y, Sakaguchi H, Ohuchi H, Kurosaki K. Tsuda E, et al. J Cardiol. 2022 Dec;80(6):557-562. doi: 10.1016/j.jjcc.2022.07.016. Epub 2022 Aug 10. J Cardiol. 2022. PMID: 35961804 Review.
BACKGROUND: We reviewed the long-term outcome of children with hypertrophic cardiomyopathy (HCM) based on the type. METHODS: We reviewed the medical records of 100 patients (male 54 female 46) with HCM at our hospital between 1977 and 2015. ...RESULTS: The age at th …
BACKGROUND: We reviewed the long-term outcome of children with hypertrophic cardiomyopathy (HCM) based on the type. METHODS: W …
Mitral Valve Disease in Hypertrophic Cardiomyopathy:Evaluation and Management.
Jain CC, Newman DB, Geske JB. Jain CC, et al. Curr Cardiol Rep. 2019 Oct 31;21(11):136. doi: 10.1007/s11886-019-1231-8. Curr Cardiol Rep. 2019. PMID: 31673812 Review.
PURPOSE OF REVIEW: To discuss the critical role of the mitral valve (MV) in the pathophysiology of obstruction in hypertrophic cardiomyopathy (HCM), evaluation of the MV in HCM, the impact of MV characteristics on treatment in HCM, and management of the MV at the ti …
PURPOSE OF REVIEW: To discuss the critical role of the mitral valve (MV) in the pathophysiology of obstruction in hypertrophic car …
Dofetilide for suppression of atrial fibrillation in hypertrophic cardiomyopathy: A case series and literature review.
Moore JC, Trager L, Anzia LE, Saliba W, Bassiouny M, Bhargava M, Chung M, Desai M, Garberich R, Lever H, Lindsay BD, Sengupta J, Tchou P, Wazni O, Wilkoff BL. Moore JC, et al. Pacing Clin Electrophysiol. 2018 Apr;41(4):396-401. doi: 10.1111/pace.13310. Epub 2018 Mar 12. Pacing Clin Electrophysiol. 2018. PMID: 29450893 Review.
BACKGROUND: Limited medical options are available for rhythm control in patients with atrial fibrillation (AF) and hypertrophic cardiomyopathy (HCM). There are no published reports of dofetilide use in this population. ...There were no adverse events during loading. …
BACKGROUND: Limited medical options are available for rhythm control in patients with atrial fibrillation (AF) and hypertrophic ca …
Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis.
Norrish G, Cantarutti N, Pissaridou E, Ridout DA, Limongelli G, Elliott PM, Kaski JP. Norrish G, et al. Eur J Prev Cardiol. 2017 Jul;24(11):1220-1230. doi: 10.1177/2047487317702519. Epub 2017 May 9. Eur J Prev Cardiol. 2017. PMID: 28482693 Review.
Conclusions A lack of well-designed, large, population-based studies in childhood hypertrophic cardiomyopathy means that the evidence base for individual risk factors is not robust. ...Multi-centre prospective studies are needed in order to further determine the rel …
Conclusions A lack of well-designed, large, population-based studies in childhood hypertrophic cardiomyopathy means that the e …
New Era: Mavacamten for Obstructive Hypertrophic Cardiomyopathy.
Woodland M, Al-Horani RA. Woodland M, et al. Cardiovasc Hematol Agents Med Chem. 2023;21(2):78-83. doi: 10.2174/1871525721666221019095218. Cardiovasc Hematol Agents Med Chem. 2023. PMID: 36278454 Review.
Obstructive hypertrophic cardiomyopathy results from asymmetric septal hypertrophy, which eventually obstructs the outflow of the left ventricle. Obstructive hypertrophic cardiomyopathy is linked to mutations in genes that encode for sarcomere proteins …
Obstructive hypertrophic cardiomyopathy results from asymmetric septal hypertrophy, which eventually obstructs the outflow of …
Review of recent advances in the management of hypertrophic cardiomyopathy.
Cao Y, Zhang PY. Cao Y, et al. Eur Rev Med Pharmacol Sci. 2017 Nov;21(22):5207-5210. doi: 10.26355/eurrev_201711_13841. Eur Rev Med Pharmacol Sci. 2017. PMID: 29228435 Free article. Review.
Hypertrophic cardiomyopathy (HCM) is a complex but common monogenic cardiovascular disorder characterized by unexplained non dilated left ventricular (LV) thickening in the absence of another cardiac or systemic disease. ...
Hypertrophic cardiomyopathy (HCM) is a complex but common monogenic cardiovascular disorder characterized by unexplained non d …
94 results